Dr. John Criscione is a professor of Biomedical Engineering at Texas A&M University who trains medical device engineers while simultaneously inventing, testing, and commercializing medical technologies. Dr. Criscione has been serving in this capacity for over 20 years and also serves as the CTO for CorInnova, a biomedical technology company focused on addressing Acute Heart Failure.
During our conversation, he discusses:
The importance of disagreement for innovation
Translating inventions into marketable products
The challenges of new technologies and indications in medical devices
The pivotal role of angel investors in technology development
Navigating the 'valley of death' in medical technology commercialization
The specific difficulties of pediatric medical devices
Partnering for commercialization versus solo invention
The role and impact of the Southwest Pediatric Device Consortium
Listen now on Spotify, Apple Podcasts, and YouTube.
What We Cover:
00:00 The Nature of Innovation
04:08 John’s Journey into Biomedical Engineering
06:09 Challenges in Medical Technology
10:47 The Valley of Death in Medical Innovation
13:57 Funding and Investment Challenges
15:12 CorInnova's Inception and Early Years
20:51 The Double Whammy of New Technologies
25:59 The Role of Angel Investors
28:33 The Burdens of Innovation
35:52 Challenges in Pediatric Medical Devices
40:20 Key Questions for Pediatric Device Investment
Connect with Dr. Criscione:
LinkedIn: https://www.linkedin.com/in/john-criscione-6a56833/
Website: https://swpdc.org/
Website: https://www.corinnova.com/
Connect with Andrew
Newsletter: https://thediligentobserver.substack.com
Website: https://pitchfact.com/
Stuff We Reference
Texas A&M University: https://www.tamu.edu/index.html
Boulder Grading: https://www.99boulders.com/bouldering-grades
The Ozarks: https://mostateparks.com/page/57896/lake-ozarks-region
Johns Hopkins University: https://www.jhu.edu/
Aggie Angel Network: https://mcferrin.tamu.edu/program/aggie-angel-network/
William Altman: https://www.linkedin.com/in/williamcaltman/
Harvard University: https://www.harvard.edu/
McKinsey: https://www.mckinsey.com/
Houston Angel Network: https://www.houstonangelnetwork.org/
National Institutes of Health (NIH): https://www.nih.gov/
SBIR: https://www.sbir.gov/
American Heart Assocation: https://www.heart.org/
American Cancer Society: https://www.cancer.org/
All opinions expressed are personal and may not reflect the views of the individual’s organization or of The Diligent Observer. Not investment advice.












